Melanoma (Skin) Stage IV Completed Phase 2 Trials for Selumetinib (DB11689)
Also known as: Stage 4 Melanoma / Melanoma Stage Iv / Stage IV Skin Melanoma / Stage IV Melanoma
| Indication | Status | Phase |
|---|---|---|
| DBCOND0109891 (Melanoma (Skin) Stage IV) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00866177 | MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma | Treatment |